Coherent Corp. launches Chameleon Discovery LX, a femtosecond laser optimized for nonlinear microscopy and ultrafast spectroscopy.
Quiver AI Summary
Coherent Corp. has announced the launch of the Chameleon Discovery LX, a new femtosecond laser designed for nonlinear microscopy and ultrafast spectroscopy, featuring ultrashort 100 fs pulses and a tunable wavelength range from 680 to 1080 nm with output powers of 3.2 W. This addition to the Chameleon Discovery product line incorporates advanced capabilities like built-in wide dispersion precompensation and fast power modulation to enhance high-speed imaging in various research fields, including neuroscience and immunology. The Discovery LX aims to address the growing demand for reliable laser sources in advanced microscopy applications, offering optimized performance and support for researchers. Orders for the Discovery LX are now being accepted, and further details can be found on Coherent's website.
Potential Positives
- Coherent Corp. launched the Chameleon Discovery LX, enhancing its product lineup in the nonlinear microscopy and ultrafast spectroscopy markets.
- The Chameleon Discovery LX features advanced technology, such as ultrashort 100 fs pulses and tunable wavelength range, positioning the company as a leader in innovative laser solutions.
- The press release indicates a commitment to ongoing research and development, showcasing their expertise and investment in advancing microscopy applications.
- The Discovery LX's optimized design and reliability support a growing market demand for superior laser sources in diverse research applications.
Potential Negatives
- None
FAQ
What is the Chameleon Discovery LX?
The Chameleon Discovery LX is a new femtosecond laser designed for nonlinear microscopy and ultrafast spectroscopy, featuring ultrashort 100 fs pulses.
What are the key features of the Chameleon Discovery LX?
It offers a tunable wavelength range of 680 to 1080 nm, 3.2 W output powers, fast power modulation, and built-in wide dispersion precompensation.
Who can benefit from the Chameleon Discovery LX?
This device is optimized for researchers in fields such as neuroscience, immunology, and disease research, particularly those using multiphoton microscopy.
How does the Discovery LX differ from the Discovery NX?
The Discovery LX provides single-tunable-output laser capabilities, while the Discovery NX features dual-output capabilities for more advanced research applications.
Where can I order the Chameleon Discovery LX?
The Chameleon Discovery LX is available for orders through Coherent's website at www.coherent.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$COHR Insider Trading Activity
$COHR insiders have traded $COHR stock on the open market 28 times in the past 6 months. Of those trades, 4 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $COHR stock by insiders over the last 6 months:
- HOWARD H. XIA has traded it 3 times. They made 0 purchases and 3 sales, selling 2,970 shares.
- CHRISTOPHER KOEPPEN (Chief Innovation Officer) has traded it 10 times. They made 0 purchases and 10 sales, selling 12,665 shares.
- JAMES ROBERT ANDERSON (CEO & President) has traded it 4 times. They made 4 purchases, buying 2,000 shares and 0 sales.
- JOSEPH J CORASANTI has traded it 2 times. They made 0 purchases and 2 sales, selling 18,210 shares.
- ELIZABETH PATRICK has traded it 2 times. They made 0 purchases and 2 sales, selling 5,542 shares.
- RONALD BASSO (Chief Legal & Compliance Off.) sold 4,741 shares.
- WALTER ROBERT II BASHAW (President) has traded it 6 times. They made 0 purchases and 6 sales, selling 6,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$COHR Hedge Fund Activity
We have seen 276 institutional investors add shares of $COHR stock to their portfolio, and 286 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DODGE & COX removed 3,374,245 shares (-24.1%) from their portfolio in Q3 2024
- FMR LLC added 3,281,346 shares (+86.4%) to their portfolio in Q3 2024
- INVESCO LTD. added 2,837,349 shares (+33.0%) to their portfolio in Q3 2024
- BLACKROCK, INC. added 2,620,795 shares (+21.3%) to their portfolio in Q3 2024
- POINT72 ASSET MANAGEMENT, L.P. removed 1,833,740 shares (-43.9%) from their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP added 1,478,447 shares (+39.2%) to their portfolio in Q3 2024
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,092,405 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Image 1: Chameleon Discovery LX
PITTSBURGH, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in laser and photonics solutions, announces the launch of the Chameleon Discovery LX, the latest addition to the successful Chameleon Discovery product line. Designed for researchers in nonlinear microscopy and ultrafast spectroscopy, this advanced femtosecond laser delivers exceptional performance and versatility to meet evolving market needs.
The Chameleon Discovery LX provides ultrashort 100 fs pulses and features a tunable wavelength range from 680 to 1080 nm with industry-leading output powers of 3.2 W at the peak of the tuning curve. It integrates advanced features such as built-in wide dispersion precompensation and fast power modulation, enabling deep, high-speed imaging that is optimized for key fluorophores in multiphoton microscopy.
“The Discovery LX represents a new milestone in over two decades of expertise in tunable femtosecond laser technology,” said Darryl McCoy, Vice President & General Manager, Coherent. “Its innovative design and unparalleled performance reaffirm our commitment to advancing nonlinear microscopy applications.”
The nonlinear microscopy market continues to thrive, with applications spanning neuroscience, immunology, and disease research, along with an increasing interest in using it in clinical settings. As microscopy techniques advance, the need for laser sources with superior reliability and more advanced parameters grows. The Discovery LX meets these demands with an optimized design tailored for all key nonlinear microscopy applications.
Building on the success of the flagship Discovery NX platform, the Discovery LX offers researchers a broader range of solutions, delivering precision and reliability backed by comprehensive global service and support for reliable, long-term operation.
The Chameleon Discovery product line now includes:
- Discovery NX : Dual-output capabilities for advanced research.
- Discovery LX : Single-tunable-output laser optimized for specific applications.
The successful Axon product line provides femtosecond pulses in a compact format and at discrete wavelengths.
These lasers can also be paired with various accessories to extend their spectral coverage, addressing a broad range of research needs.
The Discovery LX is now available for orders. For more information, visit www.coherent.com .
About Coherent
Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at coherent.com .
Media Contact :
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/5ce6c6fc-3081-4ad3-9ae4-8f7559fe72e9